Tarsons profit drops 52% as finance costs and excess pay weigh
Profit collapsed to ₹14.3 crore despite top-line growth, while the company revealed it overpaid its top executives by ₹4.1 crore.
— 2 earlier stories on Tarsons Products Ltd. →What's new
- Profit slumped to ₹14.3 crore even as revenue grew 7.7% to ₹422.5 crore.
- Depreciation surged 54%, compounding the squeeze from higher finance costs.
- Management seeks shareholder approval to waive ₹4.1 crore in excess remuneration paid to directors.
Why it matters
The delta between modest revenue growth and a halving of profits is the clearest signal of operational strain. Paying executives in excess of approved limits is an avoidable governance headache for a firm already struggling with margin compression.
What we're watching
- Whether shareholders approve the waiver for the excess executive payouts.
- Evidence of margin recovery in the next quarterly results.
- Capex efficiency given the sharp jump in depreciation expenses.
The full read
Tarsons Products ended the year with a sharp disconnect between its revenue and its bottom line. While domestic sales helped push revenue up 7.7% to ₹422.5 crore, consolidated net profit fell 52% to ₹14.3 crore. The culprit is a classic combination of scaling costs: depreciation surged 54% during the period, and rising finance costs further drained the residual earnings. Beyond the numbers, the board is dealing with a compliance issue, having paid ₹4.1 crore in remuneration to its managing director and whole-time director that exceeded established limits. It must now ask shareholders to sign off on the error. For a micro-cap, this level of profit erosion is the primary concern, as it suggests the company’s recent capacity expansion has yet to find the volume needed to cover its debt and depreciation load. The shareholder vote on executive pay is now the next hurdle.